Acotif 300 contains Acotiamide Hydrochloride Hydrate, a first-in-class prokinetic agent and the world’s first approved treatment for Postprandial Distress Syndrome (PDS) — a key symptom cluster of Functional Dyspepsia (FD).
Alenza-B is a fixed-dose combination of Bilastine and Montelukast Sodium, formulated for effective and well-tolerated treatment of allergic conditions.
Bilastine is a next-generation, non-sedating, highly selective H1 receptor antagonist from the piperidine class, structurally distinct from other antihistamines.
Montelukast is a leukotriene receptor antagonist that synergizes with Bilastine to enhance anti-allergic and anti-inflammatory action.
This combination offers additive therapeutic benefits as demonstrated in both in vitro and in vivo
Alenza-FX is a fixed-dose combination of Fexofenadine and Montelukast Sodium, formulated for effective and well-tolerated treatment of allergic conditions.
Fexofenadine is a Second-generation selective H1 antihistamine.
Montelukast is a leukotriene receptor antagonist that synergizes with Bilastine to enhance anti-allergic and anti-inflammatory action.
This combination offers additive therapeutic benefits as demonstrated in both in vitro and in vivo
Allergic disorders such as allergic rhinitis, seasonal allergies, perennial allergies, and allergic cough are increasingly common in both children and adults. Exposure to allergens like pollen, dust mites, pet dander, mold, and environmental pollutants can trigger symptoms including sneezing, runny nose, nasal congestion, itching, watery eyes, and persistent cough. In susceptible individuals, these conditions may also aggravate asthma symptoms and reduce quality of life.
Effective allergy management requires controlling both the histamine-mediated allergic response and the leukotriene-mediated inflammatory pathway. Combining an antihistamine with a leukotriene receptor antagonist offers superior symptom control and helps prevent recurrence of allergic episodes.
ALENZA M combines Levocetirizine Hydrochloride, a potent second-generation antihistamine, with Montelukast Sodium, a leukotriene receptor antagonist, to provide comprehensive and long-lasting relief from allergic conditions in both pediatric and adult patients.
Alenza-FX is a fixed-dose combination of Fexofenadine and Montelukast Sodium, formulated for effective and well-tolerated treatment of allergic conditions.
Alenza-L is a fixed-dose combination of Levocetirizine and Montelukast Sodium, formulated for effective and well-tolerated treatment of allergic conditions.
Levocetirizine is a third generation H1- antihistamine.
Montelukast is a leukotriene receptor antagonist that synergizes with Bilastine to enhance anti-allergic and anti-inflammatory action.
This combination offers additive therapeutic benefits as demonstrated in both in vitro and in vivo
Excellent — that combination is a joint health and cartilage support supplement, commonly used for osteoarthritis, joint stiffness, and bone strength.
a) Collagen Peptide Type I (Non-Hydrolyzed) – 40 mg
Collagen Type I is the main structural protein in bones, tendons, skin, and cartilage.
It helps maintain joint flexibility and strengthen connective tissues.
Non-hydrolyzed means it’s closer to the natural collagen form, but less easily absorbed than hydrolyzed peptides — still contributes to cartilage health.
b) Chondroitin Sulphate – 200 mg
A natural component of cartilage that helps retain water and elasticity in joints.
Reduces cartilage breakdown and joint pain, particularly in osteoarthritis.
Often used with glucosamine or collagen to support joint cushioning.
c) Sodium Hyaluronate – 30 mg
The salt form of hyaluronic acid, a lubricating molecule found in joint (synovial) fluid.
Acts like a “joint lubricant and shock absorber”, improving movement and reducing friction.
Also promotes cartilage repair and reduces joint inflammation.
d) Vitamin C – 35 mg
An essential antioxidant that helps in collagen synthesis.
Reduces oxidative stress and inflammation in joints.
Supports immune health and improves collagen peptide effectiveness.
B-NUTRA 10% is a sterile, non-pyrogenic, hypertonic solution containing essential and non-essential amino acids along with electrolytes. It is designed for parenteral nutrition in patients requiring intravenous nutritional support.
BNUTRA 1.0 is a complete and balanced enteral nutrition formula enriched with:
25 g high-quality protein
8 g dietary fiber including FOS (Fructooligosaccharides)
447 kcal per 100 g
39 essential nutrients including 13 immunity-supporting components
It is ideal for patients requiring nutritional support via oral or tube feeding, and is sucrose-free, trans fat-free, gluten-free, and low in electrolytes — making it suitable for individuals with special dietary needs, including those with diabetes.
